Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer.
Tamari S, Menju T, Toyazaki T, Miyamoto H, Chiba N, Noguchi M, Ishikawa H, Miyata R, Kayawake H, Tanaka S, Yamada Y, Yutaka Y, Nakajima D, Ohsumi A, Hamaji M, Date H. Tamari S, et al. Among authors: noguchi m. Oncol Rep. 2022 Oct;48(4):171. doi: 10.3892/or.2022.8386. Epub 2022 Aug 12. Oncol Rep. 2022. PMID: 35959810
T-cell chimerism prior to graft-versus-host disease.
Noguchi M, Shindo T, Yamada Y, Date H. Noguchi M, et al. Eur J Cardiothorac Surg. 2021 Jul 14;60(1):194-196. doi: 10.1093/ejcts/ezaa484. Eur J Cardiothorac Surg. 2021. PMID: 33495782
Prognostic significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the literature.
Nakajima N, Yoshizawa A, Rokutan-Kurata M, Noguchi M, Teramoto Y, Sumiyoshi S, Kondo K, Sonobe M, Hamaji M, Menju T, Date H, Haga H. Nakajima N, et al. Among authors: noguchi m. Transl Lung Cancer Res. 2021 Jan;10(1):117-127. doi: 10.21037/tlcr-20-612. Transl Lung Cancer Res. 2021. PMID: 33569298 Free PMC article.
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer.
Moriya T, Hamaji M, Yoshizawa A, Miyata R, Noguchi M, Tamari S, Chiba N, Miyamoto H, Toyazaki T, Tanaka S, Yamada Y, Yutaka Y, Nakajima D, Ohsumi A, Menju T, Date H. Moriya T, et al. Among authors: noguchi m. Interact Cardiovasc Thorac Surg. 2022 Feb 21;34(3):416-423. doi: 10.1093/icvts/ivab283. Interact Cardiovasc Thorac Surg. 2022. PMID: 34652430 Free PMC article.
A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial-mesenchymal transition.
Ishikawa H, Menju T, Toyazaki T, Miyamoto H, Chiba N, Noguchi M, Tamari S, Miyata R, Yutaka Y, Tanaka S, Yamada Y, Nakajima D, Ohsumi A, Hamaji M, Okuno Y, Date H. Ishikawa H, et al. Among authors: noguchi m. Lung Cancer. 2023 Jan;175:36-46. doi: 10.1016/j.lungcan.2022.11.015. Epub 2022 Nov 23. Lung Cancer. 2023. PMID: 36450215
2,427 results